Literature DB >> 22453912

Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy.

B Stratmann1, D Tschöpe.   

Abstract

Epidemiological studies have reported on the association between diabetes mellitus (DM) and subsequent risk of atrial fibrillation (AF) with inconsistent results. Individuals with DM present with an increased risk (approximate 40%) of subsequent AF compared with unaffected individuals, but the mechanisms underlying the relationship between DM and AF remains speculative. Both entities share common risk factors and, thus, seem to be closely associated with each other. Obviously, the quality of glycemic control is directly related with the risk for AF; the risk is higher with longer duration of treated diabetes and poorer glycemic control. Future research should identify approaches to reduce the risk of AF in people with diabetes by means of consequent screening and anti-coagulation therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453912     DOI: 10.1007/s00059-012-3600-6

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  48 in total

1.  Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation.

Authors:  M J Mihm; F Yu; C A Carnes; P J Reiser; P M McCarthy; D R Van Wagoner; J A Bauer
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

2.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

Authors:  Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

3.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  Lars Frost; Lone Juul Hune; Peter Vestergaard
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

4.  Diabetes mellitus, glycemic control, and risk of atrial fibrillation.

Authors:  Sascha Dublin; Nicole L Glazer; Nicholas L Smith; Bruce M Psaty; Thomas Lumley; Kerri L Wiggins; Richard L Page; Susan R Heckbert
Journal:  J Gen Intern Med       Date:  2010-04-20       Impact factor: 5.128

5.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

6.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

7.  Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.

Authors:  C J Ostgren; J Merlo; L Råstam; U Lindblad
Journal:  Diabetes Obes Metab       Date:  2004-09       Impact factor: 6.577

8.  Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial).

Authors:  Tonje Amb Aksnes; Roland E Schmieder; Sverre Erik Kjeldsen; Sajda Ghani; Tsushung Augie Hua; Stevo Julius
Journal:  Am J Cardiol       Date:  2008-01-15       Impact factor: 2.778

9.  Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK.

Authors:  Ana Ruigómez; Saga Johansson; Mari-Ann Wallander; Luis Alberto García Rodríguez
Journal:  BMC Cardiovasc Disord       Date:  2005-07-11       Impact factor: 2.298

10.  Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects.

Authors:  Odd Erik Johansen; Ellen Brustad; Steve Enger; Arnljot Tveit
Journal:  Cardiovasc Diabetol       Date:  2008-09-28       Impact factor: 9.951

View more
  2 in total

Review 1.  Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?

Authors:  M Matta; A Saglietto; P De Salvo; A Bissolino; A Ballatore; M Anselmino
Journal:  Herz       Date:  2019-05       Impact factor: 1.443

2.  Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2.

Authors:  Nina A Dzhoyashvili; Anastasia Yu Efimenko; Tatiana N Kochegura; Natalia I Kalinina; Natalia V Koptelova; Olga Yu Sukhareva; Marina V Shestakova; Renat S Akchurin; Vsevolod A Tkachuk; Yelena V Parfyonova
Journal:  J Transl Med       Date:  2014-12-10       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.